UK markets closed

NewAmsterdam Pharma Company N.V. (KH6.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
19.30+0.10 (+0.52%)
At close: 03:29PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
93,500
14,090
102,694
0
0
Operating expenses
Research development
47,313
159,424
86,744
28,974
4,975
Selling general and administrative
12,402
29,771
14,015
5,677
1,515
Total operating expenses
59,763
189,195
100,759
34,651
6,492
Operating income or loss
33,737
-175,105
1,935
-34,651
-6,492
Interest expense
264
0
287
411
423.1034
Total other income/expenses net
1,904
-5,226
-18,790
-6,397
29.5188
Income before tax
35,396
-176,910
-22,634
-41,785
-7,071
Income tax expense
0
27
0
0
0
Income from continuing operations
35,396
-176,937
-22,634
-41,785
-7,071
Net income
35,396
-176,937
-22,634
-41,785
-7,071
Net income available to common shareholders
35,396
-176,937
-22,634
-41,785
-7,071
Basic EPS
-2.52
-
-1.19
-3.81
-0.64
Diluted EPS
-2.52
-
-1.19
-3.81
-0.64
Basic average shares
82,324
-
18,966
10,967
10,967
Diluted average shares
82,324
-
18,966
10,967
10,967